Maaike van der Aa
Overview
Explore the profile of Maaike van der Aa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ye Y, Timmermans M, van der Aa M, le Cessie S, Jonges G, Janse J, et al.
Int J Gynecol Cancer
. 2025 Feb;
35(2):100047.
PMID: 39971433
Objective: To evaluate the influence of intrauterine manipulators on oncological outcomes in early-stage, low-grade endometrioid endometrial cancer. Methods: This retrospective, nationwide population-based study included all women International Federation of Gynecology...
2.
Algera M, Van de Vijver K, van Driel W, Slangen B, Lof F, van der Aa M, et al.
Int J Gynecol Cancer
. 2024 Mar;
34(5):722-729.
PMID: 38460968
Objective: This study aimed to assess the outcomes of patients with early stage mucinous ovarian carcinoma based on subtype (expansile vs infiltrative). Methods: We retrospectively analyzed all surgically treated patients...
3.
Seignette K, Jamann N, Papale P, Terra H, Porneso R, de Kraker L, et al.
Elife
. 2024 Jan;
12.
PMID: 38192196
Detailed characterization of interneuron types in primary visual cortex (V1) has greatly contributed to understanding visual perception, yet the role of chandelier cells (ChCs) in visual processing remains poorly characterized....
4.
van Wagensveld L, Walker C, Hahn K, Sanders J, Kruitwagen R, van der Aa M, et al.
Res Sq
. 2023 Nov;
PMID: 38014112
Introduction: Tumor-stroma ratio (TSR) is prognostic in multiple cancers, while its role in high-grade serous ovarian cancer (HGSOC) remains unclear. Despite the prognostic insight gained from genetic profiles and tumor-infiltrating...
5.
Olthof E, Wenzel H, van der Velden J, Spijkerboer A, Bekkers R, Beltman J, et al.
Int J Gynecol Cancer
. 2022 Apr;
32(7):861-868.
PMID: 35483738
Objective: Treatment strategies for bulky lymph nodes in patients with locally advanced cervical cancer scheduled for definitive chemoradiation include nodal boosting with radiotherapy, surgical debulking, or both. The aim of...
6.
You B, van Wagensveld L, Tod M, Sonke G, Horlings H, Kruitwagen R, et al.
Br J Cancer
. 2022 Apr;
127(1):79-83.
PMID: 35361918
Background: In ovarian carcinomas, the likelihood of disease cure following first-line medical-surgical treatment has been poorly addressed. The objective was to: (a) assess the likelihood of long-term disease-free (LDF) > ...
7.
Hermens M, Van Altena A, van der Aa M, Bulten J, van Vliet H, Siebers A, et al.
Int J Cancer
. 2021 Dec;
150(9):1439-1446.
PMID: 34921730
We aim to compare endometrial cancer survival in women with or without histological proven endometriosis or adenomyosis. We identified all women with endometrial cancer between 1990 and 2015 from the...
8.
Van Weelden W, Bretveld R, Romano A, van Erp S, Engels S, Lalisang R, et al.
Int J Gynecol Cancer
. 2021 May;
31(7):1014-1020.
PMID: 34001633
Introduction: According to current guidelines, hormonal therapy may be applied in endometrioid type endometrial cancer as an alternative to surgery for fertility preservation and in medically unfit patients. Since it...
9.
Hermens M, Van Altena A, van der Aa M, Bulten J, van Vliet H, Siebers A, et al.
Am J Obstet Gynecol
. 2020 Aug;
224(3):284.e1-284.e10.
PMID: 32841629
Background: Contradicting results regarding ovarian cancer prognosis in women with endometriosis have been reported in the literature. Owing to the small sample size of previous studies, larger studies are required...
10.
Burg L, Timmermans M, van der Aa M, Boll D, Rovers K, de Hingh I, et al.
J Gynecol Oncol
. 2020 Aug;
31(5):e58.
PMID: 32808491
Objective: Peritoneal metastases (PM) are a challenge in gynecological cancers, but its appearance has never been described in a population-based study. Therefore, we describe the incidence of PM and identify...